Extracorporeal Blood Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.

The global market for Extracorporeal Blood Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Blood Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Extracorporeal Blood Treatment by region & country, by Type, and by Application.

The Extracorporeal Blood Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Blood Treatment.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Extracorporeal Blood Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Extracorporeal Blood Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Extracorporeal Blood Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Extracorporeal Blood Treatment Product Introduction
    1.2 Global Extracorporeal Blood Treatment Market Size Forecast
    1.3 Extracorporeal Blood Treatment Market Trends & Drivers
        1.3.1 Extracorporeal Blood Treatment Industry Trends
        1.3.2 Extracorporeal Blood Treatment Market Drivers & Opportunity
        1.3.3 Extracorporeal Blood Treatment Market Challenges
        1.3.4 Extracorporeal Blood Treatment Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Extracorporeal Blood Treatment Players Revenue Ranking (2023)
    2.2 Global Extracorporeal Blood Treatment Revenue by Company (2019-2024)
    2.3 Key Companies Extracorporeal Blood Treatment Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Extracorporeal Blood Treatment Product Offered
    2.5 Key Companies Time to Begin Mass Production of Extracorporeal Blood Treatment
    2.6 Extracorporeal Blood Treatment Market Competitive Analysis
        2.6.1 Extracorporeal Blood Treatment Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Extracorporeal Blood Treatment Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Blood Treatment as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Hemodialysis
        3.1.2 Acute dialysis
        3.1.3 Apheresis
    3.2 Global Extracorporeal Blood Treatment Sales Value by Type
        3.2.1 Global Extracorporeal Blood Treatment Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Extracorporeal Blood Treatment Sales Value, by Type (2019-2030)
        3.2.3 Global Extracorporeal Blood Treatment Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Severe Sepsis
        4.1.2 Acute Lung Injury
        4.1.3 Liver Failure
        4.1.4 Cardiogenic Shock
    4.2 Global Extracorporeal Blood Treatment Sales Value by Application
        4.2.1 Global Extracorporeal Blood Treatment Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Extracorporeal Blood Treatment Sales Value, by Application (2019-2030)
        4.2.3 Global Extracorporeal Blood Treatment Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Extracorporeal Blood Treatment Sales Value by Region
        5.1.1 Global Extracorporeal Blood Treatment Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Extracorporeal Blood Treatment Sales Value by Region (2019-2024)
        5.1.3 Global Extracorporeal Blood Treatment Sales Value by Region (2025-2030)
        5.1.4 Global Extracorporeal Blood Treatment Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Extracorporeal Blood Treatment Sales Value, 2019-2030
        5.2.2 North America Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Extracorporeal Blood Treatment Sales Value, 2019-2030
        5.3.2 Europe Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Extracorporeal Blood Treatment Sales Value, 2019-2030
        5.4.2 Asia Pacific Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Extracorporeal Blood Treatment Sales Value, 2019-2030
        5.5.2 South America Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Extracorporeal Blood Treatment Sales Value, 2019-2030
        5.6.2 Middle East & Africa Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Extracorporeal Blood Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Extracorporeal Blood Treatment Sales Value
    6.3 United States
        6.3.1 United States Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.3.2 United States Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.4.2 Europe Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.5.2 China Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.6.2 Japan Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.7.2 South Korea Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.8.2 Southeast Asia Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Extracorporeal Blood Treatment Sales Value, 2019-2030
        6.9.2 India Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Extracorporeal Blood Treatment Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Fresenius Medical Care
        7.1.1 Fresenius Medical Care Profile
        7.1.2 Fresenius Medical Care Main Business
        7.1.3 Fresenius Medical Care Extracorporeal Blood Treatment Products, Services and Solutions
        7.1.4 Fresenius Medical Care Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.1.5 Fresenius Medical Care Recent Developments
    7.2 DaVita Kidney Care
        7.2.1 DaVita Kidney Care Profile
        7.2.2 DaVita Kidney Care Main Business
        7.2.3 DaVita Kidney Care Extracorporeal Blood Treatment Products, Services and Solutions
        7.2.4 DaVita Kidney Care Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.2.5 DaVita Kidney Care Recent Developments
    7.3 Renal Care
        7.3.1 Renal Care Profile
        7.3.2 Renal Care Main Business
        7.3.3 Renal Care Extracorporeal Blood Treatment Products, Services and Solutions
        7.3.4 Renal Care Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.3.5 Dialysis Clinic Recent Developments
    7.4 Dialysis Clinic
        7.4.1 Dialysis Clinic Profile
        7.4.2 Dialysis Clinic Main Business
        7.4.3 Dialysis Clinic Extracorporeal Blood Treatment Products, Services and Solutions
        7.4.4 Dialysis Clinic Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.4.5 Dialysis Clinic Recent Developments
    7.5 American Renal Associates
        7.5.1 American Renal Associates Profile
        7.5.2 American Renal Associates Main Business
        7.5.3 American Renal Associates Extracorporeal Blood Treatment Products, Services and Solutions
        7.5.4 American Renal Associates Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.5.5 American Renal Associates Recent Developments
    7.6 Satellite Healthcare
        7.6.1 Satellite Healthcare Profile
        7.6.2 Satellite Healthcare Main Business
        7.6.3 Satellite Healthcare Extracorporeal Blood Treatment Products, Services and Solutions
        7.6.4 Satellite Healthcare Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.6.5 Satellite Healthcare Recent Developments
    7.7 Atlantic Dialysis Management
        7.7.1 Atlantic Dialysis Management Profile
        7.7.2 Atlantic Dialysis Management Main Business
        7.7.3 Atlantic Dialysis Management Extracorporeal Blood Treatment Products, Services and Solutions
        7.7.4 Atlantic Dialysis Management Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.7.5 Atlantic Dialysis Management Recent Developments
    7.8 Northwest Kidney Centers
        7.8.1 Northwest Kidney Centers Profile
        7.8.2 Northwest Kidney Centers Main Business
        7.8.3 Northwest Kidney Centers Extracorporeal Blood Treatment Products, Services and Solutions
        7.8.4 Northwest Kidney Centers Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.8.5 Northwest Kidney Centers Recent Developments
    7.9 Centers for Dialyssis Care
        7.9.1 Centers for Dialyssis Care Profile
        7.9.2 Centers for Dialyssis Care Main Business
        7.9.3 Centers for Dialyssis Care Extracorporeal Blood Treatment Products, Services and Solutions
        7.9.4 Centers for Dialyssis Care Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.9.5 Centers for Dialyssis Care Recent Developments
    7.10 Rogosin Institute
        7.10.1 Rogosin Institute Profile
        7.10.2 Rogosin Institute Main Business
        7.10.3 Rogosin Institute Extracorporeal Blood Treatment Products, Services and Solutions
        7.10.4 Rogosin Institute Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.10.5 Rogosin Institute Recent Developments
    7.11 B. Braun
        7.11.1 B. Braun Profile
        7.11.2 B. Braun Main Business
        7.11.3 B. Braun Extracorporeal Blood Treatment Products, Services and Solutions
        7.11.4 B. Braun Extracorporeal Blood Treatment Revenue (US$ Million) & (2019-2024)
        7.11.5 B. Braun Recent Developments

 8 Industry Chain Analysis
    8.1 Extracorporeal Blood Treatment Industrial Chain
    8.2 Extracorporeal Blood Treatment Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Extracorporeal Blood Treatment Sales Model
        8.5.2 Sales Channel
        8.5.3 Extracorporeal Blood Treatment Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Extracorporeal Blood Treatment Market Trends
    Table 2. Extracorporeal Blood Treatment Market Drivers & Opportunity
    Table 3. Extracorporeal Blood Treatment Market Challenges
    Table 4. Extracorporeal Blood Treatment Market Restraints
    Table 5. Global Extracorporeal Blood Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Extracorporeal Blood Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Extracorporeal Blood Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Extracorporeal Blood Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Extracorporeal Blood Treatment
    Table 10. Global Extracorporeal Blood Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Blood Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Extracorporeal Blood Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Extracorporeal Blood Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Extracorporeal Blood Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Extracorporeal Blood Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Extracorporeal Blood Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Extracorporeal Blood Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Extracorporeal Blood Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Extracorporeal Blood Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Extracorporeal Blood Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Extracorporeal Blood Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Extracorporeal Blood Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Extracorporeal Blood Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Extracorporeal Blood Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Extracorporeal Blood Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Extracorporeal Blood Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Extracorporeal Blood Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Extracorporeal Blood Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Extracorporeal Blood Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Fresenius Medical Care Basic Information List
    Table 32. Fresenius Medical Care Description and Business Overview
    Table 33. Fresenius Medical Care Extracorporeal Blood Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Fresenius Medical Care (2019-2024)
    Table 35. Fresenius Medical Care Recent Developments
    Table 36. DaVita Kidney Care Basic Information List
    Table 37. DaVita Kidney Care Description and Business Overview
    Table 38. DaVita Kidney Care Extracorporeal Blood Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of DaVita Kidney Care (2019-2024)
    Table 40. DaVita Kidney Care Recent Developments
    Table 41. Renal Care Basic Information List
    Table 42. Renal Care Description and Business Overview
    Table 43. Renal Care Extracorporeal Blood Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Renal Care (2019-2024)
    Table 45. Renal Care Recent Developments
    Table 46. Dialysis Clinic Basic Information List
    Table 47. Dialysis Clinic Description and Business Overview
    Table 48. Dialysis Clinic Extracorporeal Blood Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Dialysis Clinic (2019-2024)
    Table 50. Dialysis Clinic Recent Developments
    Table 51. American Renal Associates Basic Information List
    Table 52. American Renal Associates Description and Business Overview
    Table 53. American Renal Associates Extracorporeal Blood Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of American Renal Associates (2019-2024)
    Table 55. American Renal Associates Recent Developments
    Table 56. Satellite Healthcare Basic Information List
    Table 57. Satellite Healthcare Description and Business Overview
    Table 58. Satellite Healthcare Extracorporeal Blood Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Satellite Healthcare (2019-2024)
    Table 60. Satellite Healthcare Recent Developments
    Table 61. Atlantic Dialysis Management Basic Information List
    Table 62. Atlantic Dialysis Management Description and Business Overview
    Table 63. Atlantic Dialysis Management Extracorporeal Blood Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Atlantic Dialysis Management (2019-2024)
    Table 65. Atlantic Dialysis Management Recent Developments
    Table 66. Northwest Kidney Centers Basic Information List
    Table 67. Northwest Kidney Centers Description and Business Overview
    Table 68. Northwest Kidney Centers Extracorporeal Blood Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Northwest Kidney Centers (2019-2024)
    Table 70. Northwest Kidney Centers Recent Developments
    Table 71. Centers for Dialyssis Care Basic Information List
    Table 72. Centers for Dialyssis Care Description and Business Overview
    Table 73. Centers for Dialyssis Care Extracorporeal Blood Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Centers for Dialyssis Care (2019-2024)
    Table 75. Centers for Dialyssis Care Recent Developments
    Table 76. Rogosin Institute Basic Information List
    Table 77. Rogosin Institute Description and Business Overview
    Table 78. Rogosin Institute Extracorporeal Blood Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of Rogosin Institute (2019-2024)
    Table 80. Rogosin Institute Recent Developments
    Table 81. B. Braun Basic Information List
    Table 82. B. Braun Description and Business Overview
    Table 83. B. Braun Extracorporeal Blood Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Extracorporeal Blood Treatment Business of B. Braun (2019-2024)
    Table 85. B. Braun Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Extracorporeal Blood Treatment Downstream Customers
    Table 89. Extracorporeal Blood Treatment Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Extracorporeal Blood Treatment Product Picture
    Figure 2. Global Extracorporeal Blood Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Extracorporeal Blood Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Extracorporeal Blood Treatment Report Years Considered
    Figure 5. Global Extracorporeal Blood Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Extracorporeal Blood Treatment Revenue in 2023
    Figure 7. Extracorporeal Blood Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Hemodialysis Picture
    Figure 9. Acute dialysis Picture
    Figure 10. Apheresis Picture
    Figure 11. Global Extracorporeal Blood Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Extracorporeal Blood Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Severe Sepsis
    Figure 14. Product Picture of Acute Lung Injury
    Figure 15. Product Picture of Liver Failure
    Figure 16. Product Picture of Cardiogenic Shock
    Figure 17. Global Extracorporeal Blood Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Extracorporeal Blood Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Extracorporeal Blood Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Extracorporeal Blood Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Extracorporeal Blood Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Extracorporeal Blood Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Extracorporeal Blood Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Extracorporeal Blood Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Extracorporeal Blood Treatment Sales Value (%), (2019-2030)
    Figure 30. United States Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Extracorporeal Blood Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Extracorporeal Blood Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Extracorporeal Blood Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 51. Extracorporeal Blood Treatment Industrial Chain
    Figure 52. Extracorporeal Blood Treatment Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.

The global market for Extracorporeal Blood Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Blood Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Extracorporeal Blood Treatment by region & country, by Type, and by Application.

The Extracorporeal Blood Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Blood Treatment.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Extracorporeal Blood Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Extracorporeal Blood Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Extracorporeal Blood Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.